ISO 13779-2 Testing: Chemical Composition and Purity Analysis of Hydroxyapatite Coatings

ISO 13779-2 testing addresses the chemical composition and purity of hydroxyapatite coatings applied to medical implants. Hydroxyapatite, a calcium phosphate phase, is deposited on titanium and cobalt-chromium substrates to promote bone integration. Part 2 of the ISO 13779 series specifies how the material's elemental make-up, Ca/P molar ratio, and trace impurity content are determined and judged. This article explains the underlying chemistry and measurement mechanisms, defines the scope of application, describes specimen preparation requirements, details the three principal analytical methods (XRD, ICP-OES, and FTIR), sets out how data are evaluated against acceptance limits, and outlines typical applications together with parameters that can be co-tested on the same specimens.

Principle & mechanism

The analytical basis of ISO 13779-2 rests on relating measured elemental and structural signals to the stoichiometry of hydroxyapatite, Ca10(PO4)6(OH)2. In the ideal lattice, calcium and phosphorus occupy fixed crystallographic sites with a theoretical Ca/P molar ratio of 1.67. Deviations from this ratio, or the presence of substitute ions such as carbonate, indicate secondary calcium phosphate phases or substitutional chemistry introduced during powder synthesis or coating deposition. Plasma spraying, for example, can decompose hydroxyapatite into tricalcium phosphate, tetracalcium phosphate, or amorphous calcium phosphate, all of which alter local composition. Trace elements—lead, arsenic, cadmium, mercury, and heavy metals—enter from raw materials and are controlled for biological safety. Detection proceeds by matching each impurity or phase to a physical signal: characteristic X-ray diffraction peaks for crystalline phases, atomic emission lines for elements, and infrared absorption bands for functional groups such as hydroxyl, phosphate, and carbonate. Interpretation converts these signals into concentrations and phase fractions that are compared with the standard's tabulated limits.

Scope and principle

ISO 13779-2 applies to calcium phosphate coatings and materials intended for surgical implants, covering hydroxyapatite, and related compositions in both powder and coated forms. The standard treats composition at two levels: the major constituents calcium and phosphorus, whose ratio defines the material class, and the impurities that determine purity. Its principle is straightforward—dissolve or interrogate the material with a technique suited to the analyte, quantify each component against calibrated references, and compare results with the chemical requirements stated in the standard's tables. Quantification of calcium and phosphorus, and of trace metallic impurities, is performed by spectrochemical techniques such as ICP-OES after acid digestion. Crystalline phase identification and the assessment of the hydroxyapatite fraction rely on X-ray diffraction. Infrared spectroscopy verifies the presence of hydroxyl and phosphate groups and reveals carbonate substitution. The methods are complementary: elemental analysis confirms stoichiometry and impurity burden, while structural and vibrational methods confirm that the measured elements exist as the intended phase rather than as decomposition products.

Sample preparation and requirements

Specimen preparation differs according to the analytical technique. For ICP-OES, the coating must be separated from the metallic substrate or dissolved completely. Dissolution is performed in dilute nitric acid or a nitric–hydrochloric acid mixture, chosen so that both calcium and phosphorus remain in solution without precipitation of insoluble phosphates. The dissolution reagent should be of high purity to keep blanks low. Dilution must bring calcium and phosphorus concentrations within the calibrated working range of the instrument, and internal standards such as yttrium or scandium are added to correct for matrix and nebulization effects. Calibration standards are prepared from certified single-element solutions, with matrix matching where required. For XRD, a flat, representative area of the coating is presented to the diffractometer; detached coating flakes may be ground gently to a fine, randomly oriented powder to reduce preferred orientation. Surface contamination, handling residues, and substrate grinding debris must be excluded. For FTIR, a small quantity of coating is ground with potassium bromide and pressed into a transparent pellet, or examined by an attenuated-total-reflectance accessory. Documentation of sampling location and coating condition accompanies each specimen.

Test methods — XRD, ICP-OES and FTIR

X-ray diffraction is conducted over an angular range that encompasses the principal hydroxyapatite reflections and those of likely secondary phases such as alpha- and beta-tricalcium phosphate, tetracalcium phosphate, and calcium oxide. Peak positions identify phases; relative peak intensities indicate which secondary phases exceed the detection capability. Quantitative or semi-quantitative phase estimates follow the standard's guidance on comparing patterns with reference data. ICP-OES analysis begins with acid digestion of a weighed coating portion in a closed vessel to prevent loss of volatile impurities. The solution is nebulized into an argon plasma, and emission lines for calcium, phosphorus, and each controlled trace element are measured against a multi-point calibration curve. Phosphorus is read at lines free from calcium spectral interference, and background correction is applied. Duplicate digestions establish measurement repeatability. FTIR records the absorption spectrum from the mid-infrared region: phosphate stretching and bending bands confirm the apatite framework, the hydroxyl librational band distinguishes hydroxyapatite from carbonate-substituted apatite, and carbonate bands at characteristic positions indicate B-type or A-type substitution. Spectra are compared with reference patterns for interpretation.

Data evaluation and acceptance criteria

Evaluation proceeds by comparing reported values with the compositional requirements tabulated in ISO 13779-2. The calcium-to-phosphorus molar ratio is calculated from the measured elemental concentrations after conversion to moles, and the result should lie within the range the standard assigns to hydroxyapatite; values above or below the range point to tetracalcium phosphate or tricalcium phosphate formation respectively. Each trace impurity—lead, arsenic, cadmium, mercury, and other listed heavy metals—is compared with its individual maximum permissible concentration, and results are reported on a mass-fraction basis. XRD findings are judged by whether secondary phases are detected and whether their peaks remain within the limits the standard allows; absence of peaks other than hydroxyapatite indicates that any secondary phase falls below the detection threshold. FTIR results confirm the hydroxyl and phosphate signatures expected of the apatite structure and flag carbonate substitution. Measurement uncertainty should accompany each reported value, and results near a limit are interpreted with that uncertainty in mind. Nonconforming results trigger investigation of digestion completeness, calibration validity, and sampling representativeness before retest decisions.

Applications and co-testable parameters

This testing serves manufacturers of orthopaedic and dental implants who must verify coating chemistry before release, as well as suppliers of hydroxyapatite powder seeking incoming-material qualification. Regulatory submissions and notified-body reviews routinely request composition data generated under this part of the series. The same specimens support several companion determinations: coating crystallinity and phase quantification under the crystallinity provisions of the series, coating thickness measurement by cross-sectional microscopy or non-destructive methods, adhesion strength by tensile pull-off testing, Ca/P ratio verification by X-ray fluorescence as an alternative to ICP-OES, and dissolution behaviour in buffered physiological media. Surface roughness and porosity can be assessed on adjacent coupons. Bundling these determinations into one test programme reduces specimen consumption and gives a coherent picture of coating quality, since composition influences crystallinity, which in turn governs dissolution and long-term fixation. Laboratories typically report the analytical results, the acceptance limits applied, and conformity statements for each parameter so that clients can judge batch suitability without ambiguity.